Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon.
| Title: | Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine-pyrimethamine five years (2016-2020) after the implementation of seasonal malaria chemoprevention in Cameroon. |
|---|---|
| Authors: | Tchuenkam PVK; Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, West region, Cameroon.; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Ngum LN; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Department of Biochemistry, Faculty of Science, University of Yaounde I, Yaounde, Centre, Cameroon.; Institute of Medical Research and Medicinal Plants Studies, IMPM/MINRESI, Yaoundé, Centre, BP 13033, Cameroon.; Ali IM; Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, West region, Cameroon.; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Chedjou JPK; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Department of Biochemistry, University of Buea, Buea, Southwest, P O box 63, Cameroon.; Nji AM; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Department of Biochemistry, Faculty of Science, University of Yaounde I, Yaounde, Centre, Cameroon.; Netongo PM; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Department of Biochemistry, Faculty of Science, University of Yaounde I, Yaounde, Centre, Cameroon.; Ngwafor R; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Niba PTN; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Department of Biochemistry, Faculty of Science, University of Yaounde I, Yaounde, Centre, Cameroon.; Tah CF; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Department of Biochemistry, Faculty of Science, University of Yaounde I, Yaounde, Centre, Cameroon.; Nana WD; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Department of Biochemistry, Faculty of Science, University of Yaounde I, Yaounde, Centre, Cameroon.; Ekoyol G; National Malaria Control Program, Ministry of Public Health, Yaoundé, Centre, BP 14386, Cameroon.; Bigoga JD; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Department of Biochemistry, Faculty of Science, University of Yaounde I, Yaounde, Centre, Cameroon.; Ashu DF; National Malaria Control Program, Ministry of Public Health, Yaoundé, Centre, BP 14386, Cameroon.; Tume CB; Department of Biochemistry, Faculty of Science, University of Dschang, Dschang, West region, Cameroon.; Department of Biochemistry, Faculty of Science, Universof Bamenda, Bamenda, Northwest, P.O box 39, Cameroon.; Mbacham WF; MARCAD Program, The biotechnology Centre, University of Yaounde I, Yaounde, Centre, P 0 Box 8094, Cameroon.; Department of Biochemistry, Faculty of Science, University of Yaounde I, Yaounde, Centre, Cameroon.; Centre for Health Implementation and Translation Research, The Fobang Institute, Yaoundé, Centre, BP 8094, Cameroon. |
| Source: | Wellcome open research [Wellcome Open Res] 2024 Jun 20; Vol. 9, pp. 323. Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: Wellcome Trust Country of Publication: England NLM ID: 101696457 Publication Model: eCollection Cited Medium: Print ISSN: 2398-502X (Print) Linking ISSN: 2398502X NLM ISO Abbreviation: Wellcome Open Res Subsets: PubMed not MEDLINE |
| Imprint Name(s): | Original Publication: [London] : Wellcome Trust, [2016]- |
| Abstract: | Background: Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3-59 months from 2016, raising concerns whether drug pressure may lead to a selection of known parasite resistance mutations. This study aimed at assessing the profiles of plasmodium falciparum dihydrofolate reductase (DHFR) and plasmodium falciparum dihydropteroate synthase (DHPS) gene mutations that encode enzyme targeting SP before and 5 years after the introduction of SMC in the northern part of Cameroon.; Methods: Dried blood spots were prepared from symptomatic P. falciparum-positive children prior to SPAQ administration in 2016 and after the SMC round of 2020. DNA was extracted using the Chelex-100 method, and dhfr and dhps mutations were determined after a nested polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique and agarose gel electrophoresis.; Results: 405 children with acute uncomplicated malaria were recruited. Of 405 samples, 201/405 (49.63%) were collected in 2016 and 204/405 (50.37%) were collected in 2020. High levels of mutant alleles S108N, C59R, N51I of dhfr were obtained both in 2016 and 2020 (174 (100%), 166 (95.4%), 131 (75.3%)); (140 (99.4%), 131 (92.2%), 114 (80.3%)) while the frequency of dhps mutant alleles in the A437G and K540E loci stood at 93 (51.9%) and 6 (3.4%) in 2016 and 73 (52.5%) and 4 (2.8%) in 2020, respectively. The quintuple resistant haplotype IRNGE was found in two (1.1%) and one (0.7%) in 2016 and 2020, respectively. No significant difference was observed in the frequency of the studied mutations between the two time points, although we noted a rise in the resistance conferring haplotype IRNG in 2020.; Conclusions: Continuous monitoring is recommended to preempt the widespread occurrence of high-grade resistance bearing parasites in the northern regions of Cameroon.; (Copyright: © 2024 Tchuenkam PVK et al.) |
| Competing Interests: | No competing interests were disclosed. |
| References: | Malar J. 2020 Jul 6;19(1):238. (PMID: 32631416); Malar J. 2022 Mar 24;21(1):104. (PMID: 35331231); J Infect Dis. 2015 Jun 15;211(12):1997-2005. (PMID: 25564249); Infect Dis Poverty. 2020 Jul 11;9(1):91. (PMID: 32653033); Malar J. 2017 Aug 10;16(1):325. (PMID: 28797263); Korean J Parasitol. 2022 Apr;60(2):109-116. (PMID: 35500892); Acta Trop. 2013 Dec;128(3):636-41. (PMID: 24055717); Am J Trop Med Hyg. 2012 Dec;87(6):996-1003. (PMID: 23045251); Clin Infect Dis. 2007 Apr 15;44(8):1075-7. (PMID: 17366452); Children (Basel). 2021 Oct 24;8(11):. (PMID: 34828673); J Antimicrob Chemother. 2023 Mar 2;78(3):665-668. (PMID: 36611259); Acta Trop. 2005 Sep;95(3):183-93. (PMID: 16023986); Mol Microbiol. 1997 Mar;23(5):979-86. (PMID: 9076734); Sci Rep. 2015 Nov 30;5:17412. (PMID: 26616851); Am J Trop Med Hyg. 2022 Apr 12;:. (PMID: 35413687); PLoS Clin Trials. 2006 Jul 21;1(3):e14. (PMID: 16871319); PLoS One. 2021 May 18;16(5):e0251380. (PMID: 34003847); Antimicrob Agents Chemother. 2014 Jul;58(7):3660-5. (PMID: 24733476); Int J Infect Dis. 2021 Jun;107:234-241. (PMID: 33940188); Malar J. 2018 Feb 27;17(1):98. (PMID: 29486766); Malar J. 2014 Apr 21;13:152. (PMID: 24751352); Malar J. 2013 Apr 23;12:137. (PMID: 23617576); Proc Natl Acad Sci U S A. 1990 Apr;87(8):3018-22. (PMID: 2183222); Malar J. 2010 Jun 23;9:177. (PMID: 20573194); PLoS Med. 2009 Apr 14;6(4):e1000055. (PMID: 19365539); Mol Biochem Parasitol. 1995 Jan;69(1):135-8. (PMID: 7723784); Sci Rep. 2020 Feb 26;10(1):3500. (PMID: 32103124); Lancet Microbe. 2023 Dec;4(12):e983-e993. (PMID: 37865113); Malar J. 2009 May 04;8:89. (PMID: 19413906); Parasit Vectors. 2019 Oct 26;12(1):501. (PMID: 31655608); Malar Res Treat. 2016;2016:9694372. (PMID: 27190671); Malar J. 2019 Mar 26;18(1):101. (PMID: 30914041); N Engl J Med. 2001 Jan 25;344(4):257-63. (PMID: 11172152); Malar J. 2010 Jan 27;9:34. (PMID: 20105282); Am J Trop Med Hyg. 2001 Jan-Feb;64(1-2):28-31. (PMID: 11425158); PLoS One. 2021 Aug 19;16(8):e0256343. (PMID: 34411157); Parasite Epidemiol Control. 2022 Jun 22;18:e00258. (PMID: 35789762); J Infect Dis. 2006 Apr 1;193(7):978-86. (PMID: 16518760); J Infect Dis. 2002 Feb 1;185(3):380-8. (PMID: 11807721); J Exp Biol. 2003 Nov;206(Pt 21):3745-52. (PMID: 14506209); J Infect Dis. 2003 Jun 15;187(12):1870-5. (PMID: 12792863); Malar J. 2022 Feb 8;21(1):39. (PMID: 35135546); Malar J. 2017 Apr 17;16(1):150. (PMID: 28415996); Am J Trop Med Hyg. 2011 Jul;85(1):22-5. (PMID: 21734119); Proc Natl Acad Sci U S A. 1988 Dec;85(23):9109-13. (PMID: 3057499); Malar J. 2020 Mar 4;19(1):107. (PMID: 32127009); Heliyon. 2022 Nov 23;8(11):e11861. (PMID: 36451747); PLoS Med. 2019 Mar 13;16(3):e1002762. (PMID: 30865632); Acta Trop. 2012 Sep;123(3):202-7. (PMID: 22641431); Malar Res Treat. 2018 May 02;2018:7071383. (PMID: 29854394); Exp Parasitol. 1998 May;89(1):1-8. (PMID: 9603482); Malar J. 2011 Aug 24;10:248. (PMID: 21864379); Int J Parasitol Drugs Drug Resist. 2021 Dec;17:12-22. (PMID: 34333350); Malar J. 2006 Oct 31;5:94. (PMID: 17076899); J Antimicrob Chemother. 2015 Sep;70(9):2566-71. (PMID: 26080363); Malar J. 2021 Jan 9;20(1):32. (PMID: 33422080) |
| Grant Information: | United Kingdom WT_ Wellcome Trust |
| Contributed Indexing: | Keywords: Cameroon; Pfdhps; chemoprevention; drug resistance; plasmodium falciparum; sulfadoxine–pyrimethamine; Local Abstract: [plain-language-summary] Despite all the efforts to fight against the malaria burden, it continues to be a serious threat to people's life. One of the biggest threats to the elimination and eradication of malaria is the development of resistance to known and established drugs used in the treatment and the prevention of malaria. These resistance markers accounts as a result of mutations on some Plasmodium genes. In this study, we accessed the prevalence of key resistance markers of two genes in a region where a prevention strategy (the Seasonal Malaria Chemoprevention) has been implemented for 5 years. More than 400 (201 in 2016 and 204 in 2020) patients were screened for malaria and blood samples collected to access these markers. High levels of these resistance markers were observed both in 2016 and in 2020. We found a slight increase in the resistance markers from 2016 to 2020 though it was not significant. These results raise the need to continue to closely monitor patterns of resistance. |
| Entry Date(s): | Date Created: 20241209 Latest Revision: 20250104 |
| Update Code: | 20260130 |
| PubMed Central ID: | PMC11624434 |
| DOI: | 10.12688/wellcomeopenres.22347.1 |
| PMID: | 39649624 |
| Database: | MEDLINE |
Journal Article